Malin Corporation | MLC - Market Capitalization


Malin Corporation reported EUR142.92M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 322M 180M Jun/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
ALKERMES USD 5.65B 696M Feb/2026
Avita Medical AUD 140.79M 194.8M Jun/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Eurofins Scientific SE EUR 11.01B 1.49B Jun/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
IQVIA Holdings USD 32.84B 5.54B Feb/2026
Lonza CHF 39.68B 980.61M Jun/2025
Malin Corporation EUR 150.45M 12.13M Jan/2026
Moderna USD 16.5B 6.41B Feb/2026
Organon & Co USD 1.89B 29.17M Feb/2026
Ovoca Bio EUR 7.54M 4.28M Jun/2022
Revvity USD 12.58B 1.61B Feb/2026
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 11.54B 1.06B Sep/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026